Editorial content provides updated news and information about current events, politics, weather, government and media around the world. It includes links to Web sites of news syndicates and wires, columnists and programs and daily news media. The outlet offers RSS (Really Simple Syndication).

Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.

A quarterly journal that features full-length research papers, review articles and short notes, and presents the most up-to-date findings on a broad range of topics related to the safety evaluation of drugs, chemicals and medical products. The most vital contributions to this journal encompass animal toxicology, teratology, mutagenesis, and carcinogenesis. The editorial lead time for the publication varies. Contact the publication for circulation information.

Covers law, specifically pharmaceutical and medical device product liability. Covers federal and circuit court decisions regarding liability law and analyzes recent decisions and events in ongoing court cases. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. The outlet offers RSS (Really Simple Syndication).

Circulation:The publisher does not disclose the circulationAims of the Journal:DTB articles aim to provide healthcare professionals with practical and impartial advice on treatment. The way DTB produces articles has been gradually refined since it started in 1962, but the essential principles have remained unchanged.DTB's main aims are: to provide informed and unbiased assessments of drugs and other treatments (focusing on efficacy, safety, convenience and cost in particular in relation to other available treatments); to comment on how those drugs or other treatments should be used; to assess their place in overall management, and; to review evidence and give practical advice on the overall management of disease.Over the years, DTB has initiated successful campaigns for the removal or restriction of medicines that it could not recommend, prompted withdrawal of excessive promotional claims and exposed fundamental weaknesses in certain prescribing practice. The journal claims that surveys of their readership have consistently shown that readers find DTB authoritative and influential in relation to their decisions, recommendations or advice on treatments.Content:DTB provides articles based on a synthesis of evidence with opinions from a wide range of specialist and generalist commentators, typically over 40 individuals and organisations for each article. It is aimed at doctors, pharmacists and other healthcare professionalsDTB topics include:Healthy dietsLevonogestrel IUSOsteoporosisAlprostadil creamLurasidoneDrug ShortagesPrescription ChargesOlodaterolEditorial contacts:Editor in Chief dtbeditor@bmj.comProduction Editor production.dtb@bmj.comOther information:Most articles start as a draft commissioned by one of our editorial team and written by an 'outside' expert. But the finished article is the result of detailed scrutiny, collaboration and revision involving a wide range of commentators and several editing stages. The resulting article, no longer attributable to any one source, is published unsigned and represents the view of DTB. It is not simply a distillation of the opinions of the commentators.Information on advertising can be found hereBest way to contact the Editor is by email.

Serves the academic and industrial communities with peer-reviewed coverage of basic research, development, and application principles of drug delivery and targeting at molecular, cellular, and higher levels. For academics, industrialists, and clinicians in the pharmaceutical sciences pertaining to the therapeutics of drug delivery, targeting, and controlled release. Topics covered include all delivery systems and modes of entry, such as controlled release systems; microcapsules, liposomes, vesicles, and macromolecular conjugates; antibody targeting; and protein/peptide delivery. In every issue: Letters to the Editor, Book Reviews, Announcements, Patent Briefings, Literature Alerts, and Calendars of Events.

Drug Delivery Business News provides news and information on the field of drug deliveries and the companies behind them.

Presents the latest scientific methods in drug development for professionals working in formulation development, bioavailability and solubility enhancement, drug devices, drug delivery technologies, combination products, contract services, API manufacturing, life cycle management, prefilled syringes, excipients, controlled release, fast dissolve, inhalation and nasal.

Drug Development & Delivery is a print/online content provider that presents the latest scientific methods in drug development for professionals working in Research & Development, Particle Design, APIs, Pre-formulation, Formulation Development and Analytical Methods.

Covers aspects of the development, production, and evaluation of drugs and pharmaceutical products and highlights both the technical and regulatory facets of industrial pharmacy. Topics addressed within include computerization of production, quality control, export problems, pharmacokinetics and biopharmaceutics, drug regulatory affairs, and successful manufacturing practices.